ProText Mobility, Inc. (TXTM)
0.0035
0.00 (0.00%)
USD |
OTCM |
Sep 08, 16:00
ProText Mobility Enterprise Value : 30.96M for Sept. 8, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| September 08, 2026 | 30.96M |
| September 04, 2026 | 30.96M |
| September 03, 2026 | 31.84M |
| September 02, 2026 | 30.96M |
| September 01, 2026 | 32.72M |
| August 31, 2026 | 33.60M |
| August 28, 2026 | 33.60M |
| August 27, 2026 | 35.36M |
| August 26, 2026 | 33.60M |
| August 25, 2026 | 34.48M |
| August 24, 2026 | 34.48M |
| August 21, 2026 | 32.28M |
| August 20, 2026 | 32.47M |
| August 19, 2026 | 34.92M |
| August 18, 2026 | 34.92M |
| August 17, 2026 | 32.28M |
| August 14, 2026 | 34.48M |
| August 13, 2026 | 32.72M |
| August 12, 2026 | 30.96M |
| August 11, 2026 | 33.91M |
| August 10, 2026 | 34.48M |
| August 07, 2026 | 34.22M |
| August 06, 2026 | 35.36M |
| August 05, 2026 | 34.48M |
| August 04, 2026 | 34.92M |
| Date | Value |
|---|---|
| August 03, 2026 | 37.12M |
| July 31, 2026 | 35.36M |
| July 30, 2026 | 36.24M |
| July 29, 2026 | 35.05M |
| July 28, 2026 | 34.48M |
| July 27, 2026 | 35.97M |
| July 24, 2026 | 37.12M |
| July 23, 2026 | 37.12M |
| July 22, 2026 | 37.12M |
| July 21, 2026 | 36.68M |
| July 20, 2026 | 38.88M |
| July 17, 2026 | 33.60M |
| July 16, 2026 | 33.60M |
| July 15, 2026 | 35.36M |
| July 14, 2026 | 40.63M |
| July 13, 2026 | 42.39M |
| July 10, 2026 | 39.75M |
| July 09, 2026 | 41.07M |
| July 08, 2026 | 42.39M |
| July 07, 2026 | 42.39M |
| July 06, 2026 | 42.74M |
| July 02, 2026 | 44.15M |
| July 01, 2026 | 42.39M |
| June 30, 2026 | 43.27M |
| June 29, 2026 | 42.36M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Anika Therapeutics, Inc. | 268.42M |
| Perspective Therapeutics, Inc. | 123.04M |
| Achieve Life Sciences, Inc. | 632.95M |
| MiMedx Group, Inc. | 561.90M |
| ABVC BioPharma, Inc. | 32.09M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -0.0155M |
| Total Expenses (Quarterly) | 0.0155M |
| Earnings Yield | 2.86% |